Yaz Blood Clot Risk Being Investigated by FDA

Yaz, Yasmin, Beyaz and birth control pills similar to these are the subjects of a new FDA safety review initiated yesterday, May 31. Recent studies have suggested that these drugs could have two to three times the potential to cause blood clots in users when compared with other oral contraceptives.

Recent studies have suggested that these drugs could have potential to cause blood clots in users.

These “fourth generation” progestin drospirenone pills were the subject of two studies in particular, published in the British Medical Journal, which concluded that women taking Yaz or Yasmin had twice the likelihood of having blood clots as opposed to those taking older, levonorgestrel-based birth control. No prior studies had indicated any evidence of the increased Yaz blood clot risk, notes the FDA.

For their part, the European Medicines Agency made an official determination-- just days prior— regarding the Yaz blood clot risk stating that the contraceptive and other drospirenone birth control pills were associated with a greater risk of venous thromboembolism.

Other drospirenone-containing birth control pills include:

• Safyral
• Ocella
• Syeda
• Zarah
• Gianvi
• Loryna

If you have experienced Yaz blood clots or other complications after taking Yaz, Yasmin, Beyaz, or any of their generic equivalents, fill out our free, no obligation form to the right to see if a Yaz class action lawyer can help. You may be eligible to receive compensation for your injuries through a Yaz class action lawsuit.